Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
The Journal of Rheumatology. Supplement|November 1, 1992
Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritisR M FleischmannArthritis and Rheumatism|October 31, 2009
Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritisR M FleischmannRheumatology (Oxford, England)|June 21, 2003
Addressing the safety of anakinra in patients with rheumatoid arthritisR M FleischmannClinical Therapeutics|October 6, 1999
Early diagnosis and treatment of rheumatoid arthritis for improved outcomes: focus on etanercept, a new biologic response modifierR M FleischmannArthritis and Rheumatism|September 1, 1978
Gastrointestinal systemic sclerosis in serologic mixed connective tissue diseaseD A Norman, R M FleischmannThe American Journal of Medicine|June 1, 1978
The management of renal scleroderma: experience with dialysis, nephrectomy and transplantationE C LeRoy, R M FleischmannClinical Therapeutics|July 1, 1997
A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study GroupR M Fleischmann, K Flint, G Constantine, et al.The Journal of Rheumatology|June 1, 1991
Priapism as a manifestation of isolated genital vasculitisS Lakhanpal, J T Lie, R E Karper, et al.Archives of Internal Medicine|March 29, 2000
Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluationS H Roth, R M Fleischmann, F X Burch, et al.Current Medical Research and Opinion|August 9, 2005
Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trialR M Fleischmann, S B Cohen, L W Moreland, et al.Pageof 3